Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.

Saved in:
Bibliographic Details
Title: Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.
Authors: Folkersen L; Department of Systems Biology, Technical University of Denmark, Copenhagen, Denmark.; Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Fauman E; Pfizer Worldwide Research & Development, Cambridge, Massachusetts, United States of America., Sabater-Lleal M; Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Strawbridge RJ; Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Frånberg M; Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Sennblad B; Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Baldassarre D; Dipartimento di Scienze Farmacologiche e Biomolecolari, Università di Milano, Milan, Italy.; Centro Cardiologico Monzino, IRCCS, Milan, Italy., Veglia F; Centro Cardiologico Monzino, IRCCS, Milan, Italy., Humphries SE; British Heart Foundation Laboratories, University College of London, Department of Medicine, Rayne Building, London, United Kingdom., Rauramaa R; Foundation for Research in Health Exercise and Nutrition, Kuopio Research Institute of Exercise Medicine, Kuopio, Finland., de Faire U; Division of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, and Department of Cardiology, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden., Smit AJ; Department of Medicine, University Medical Center Groningen, Groningen, the Netherlands., Giral P; Assistance Publique - Hopitaux de Paris; Service Endocrinologie-Metabolisme, Groupe Hôpitalier Pitie-Salpetriere, Unités de Prévention Cardiovasculaire, Paris, France., Kurl S; Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio Campus, Kuopio, Finland., Mannarino E; Internal Medicine, Angiology and Arteriosclerosis Diseases, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy., Enroth S; Department of Immunology, Genetics and Pathology, Science for Life Laboratory Uppsala, Uppsala University, Uppsala, Sweden., Johansson Å; Department of Immunology, Genetics and Pathology, Science for Life Laboratory Uppsala, Uppsala University, Uppsala, Sweden., Enroth SB; Department of Internal Medicine, Uppsala University Hospital, Uppsala, Sweden., Gustafsson S; Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Lind L; Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Lindgren C; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom., Morris AP; Department of Biostatistics, University of Liverpool, Liverpool, United Kingdom., Giedraitis V; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom., Silveira A; Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Franco-Cereceda A; Cardiothoracic Surgery Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Tremoli E; Dipartimento di Scienze Farmacologiche e Biomolecolari, Università di Milano, Milan, Italy.; Centro Cardiologico Monzino, IRCCS, Milan, Italy., Gyllensten U; Department of Immunology, Genetics and Pathology, Science for Life Laboratory Uppsala, Uppsala University, Uppsala, Sweden., Ingelsson E; Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, United States of America., Brunak S; Department of Systems Biology, Technical University of Denmark, Copenhagen, Denmark., Eriksson P; Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Ziemek D; Pfizer Worldwide Research & Development, Cambridge, Massachusetts, United States of America., Hamsten A; Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Mälarstig A; Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Pfizer Worldwide Research and Development, Stockholm, Sweden.
Corporate Authors: IMPROVE study group
Source: PLoS genetics [PLoS Genet] 2017 Apr 03; Vol. 13 (4), pp. e1006706. Date of Electronic Publication: 2017 Apr 03 (Print Publication: 2017).
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101239074 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7404 (Electronic) Linking ISSN: 15537390 NLM ISO Abbreviation: PLoS Genet Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1553-7404
DOI:10.1371/journal.pgen.1006706